Results 221 to 230 of about 68,452 (304)

Bottom‐Up Coacervate‐Based Artificial Cells: Integrating Cellular Hallmarks into Complex Life‐Like Systems

Angewandte Chemie, EarlyView.
Current interest in artificial cell research underscores its potential to deepen our understanding of life's fundamental processes. This review highlights advances in bottom‐up coacervate‐based artificial cell engineering via combined integration of cellular hallmarks.
Arjan Hazegh Nikroo, Angshuman Das, Madelief A. M. Verwiel, Jan C. M. van Hest   +3 more
wiley   +2 more sources

Cervical cancer immune microenvironment: Mechanisms of HPV-mediated immune evasion and advances in immunotherapy (Review). [PDF]

Oncol Lett
Zhou X, An R, Li X.
europepmc   +1 more source

Cancer therapy‐induced ototoxicity: Current challenges and emerging management strategies

Animal Models and Experimental Medicine, EarlyView.
This review comprehensively examines the key risk factors for cancer therapy‐induced ototoxicity, including cumulative drug dose, genetic susceptibility, and combined treatment regimens. It highlights current challenges in ototoxicity monitoring, such as insufficient timeliness and limited clinical adoption, and advocates for standardized auditory ...
Yuqi Huang, Baoying Xu, Xinru Chen, Yu Chen, Dehong Yu   +4 more
wiley   +1 more source

Tumor-infiltrating lymphocyte expansion protocols for adoptive cell therapy in cancer. [PDF]

Cell Oncol (Dordr)
Tovar Manzano D, Subhi-Issa N, Pereiro-Rodríguez A, López Cade IG, Mateos González M, Fernández Arquero M, Pérez Segura P, Ujaldón Miró C, Sánchez-Ramón S, Ocaña A, Guzmán Fulgencio M.   +10 more
europepmc   +1 more source

Humanized immune system animal models and their recent applications

Animal Models and Experimental Medicine, EarlyView.
In this review, we provide an updated and comprehensive overview of the current state of humanized immune system animal model research. We discuss the variety of techniques used to produce humanized mice with their respective strengths and weaknesses, and evaluate the advantages and limitations of these models, including issues with incomplete immune ...
Nicolas Skuli, Rudra B. Amin, A’ishah Bakayoko, Marisa Kruidenier, Sahara Aqui, Sarah J. Skuli, Terence P. Gade   +6 more
wiley   +1 more source

Immunotherapy for Solid Tumours: Current Clinical Landscape and Future Directions.

Eur Surg Res
van Diepen AE, Kucukcelebi S, de Vos-Geelen J, Kooreman NG.   +3 more
europepmc   +1 more source

Natural killer cells, macrophages and dendritic cells as innate immune therapies for blood cancers. [PDF]

Ann Hematol
Oriquat G, Abdulsahib WK, Ismael SH, Roopashree R, Patro PS, Nellore J, Mukherjee G, Chauhan AS, Musayeva S.   +8 more
europepmc   +1 more source

Potential of Vγ9Vδ2T cells in tuberculosis: integration of innate and adaptive immunity for vaccine development. [PDF]

PeerJ
Di D, Gao C, Deng Y, Li Y, Zhang Y.
europepmc   +1 more source

Editorial: Community series in the immunosuppressive tumor microenvironment and strategies to revert its immune regulatory milieu for cancer immunotherapy, volume II. [PDF]

Front Immunol
Ganjalikhani Hakemi M, Jayakumar N.
europepmc   +1 more source